Good morning and how are you today? The Pharmalot corporate campus is humming with activity as the short people are readying themselves for a welcome day at the schoolhouse (welcome for us, you see, because the recent Nor'easter caused power outages that kept them home the past few days). And so, we are celebrating with a strong cup of stimulation - our flavor today is Southern Pecan. Please join us. While you do, here are some interesting items to get you started. Have a good one...
Medivation Scores A Big Win With Prostate Cancer Trial (The Street)
Sanofi Profit Falls Thanks To Generic Competition (Bloomberg News)
Pfizer And Glaxo HIV Venture Plan Russian Manufacturing (Reuters)
Bristol Sued Over Benzene Exposure In Hair And Nail Products (West Virginia Record)
Merck Wins FDA Panel OK For Vytorin In Some Kidney Patients (Bloomberg News)
Medicis CEO Sells Mansion Where Girlfriend Died (Reuters)
Dendreon Offers A Lackluster Forecast (Reuters)
UK Court Backs HGS Over Lilly In Patent Fight (Pharma Times)
China FDA To Begin Overseas GMP Inspections (InPharma Technologist)
Perrigo Seeks To Make Generic Testosterone Gel (Associated Press)
Pennsylvania Offers $1.2M To Endo For Office Move (Philadelphia Inquirer)
EDITOR'S NOTE: Please check this post for updates throughout the morning